Detalhe da pesquisa
1.
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice.
Front Immunol
; 13: 1015585, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36263022
2.
Vaccine prospects for amebiasis.
Expert Rev Vaccines
; 4(5): 657-68, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16221067